
Oakland, California-based The Clorox Company (CLX) manufactures and markets consumer and professional products worldwide. With a market cap of $16.8 billion, the company operates through Health and Wellness, Household, Lifestyle, and International segments.
CLX has notably underperformed the broader market over the past year and in 2025. CLX’s stock prices have declined 3.7% over the past 52 weeks and 17.9% on a YTD basis, compared to the S&P 500 Index’s ($SPX) 12.3% gains over the past year and a marginal rise in 2025.